Stock Earnings

Question 1

How did RNAC's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Cartesian Therapeutics Inc is $-1.38, beating expectations of $-0.86.

Question 2

How did Cartesian Therapeutics Inc RNAC's revenue perform in the last quarter?

Accepted Answer

Cartesian Therapeutics Inc revenue for the last quarter is $-1.38

Question 3

What is the revenue estimate for Cartesian Therapeutics Inc?

Accepted Answer

According to 10 of Wall street analyst, the revenue estimate of Cartesian Therapeutics Inc range from $2.46M to $0.0

Question 4

What's the earning quality score for Cartesian Therapeutics Inc?

Accepted Answer

Cartesian Therapeutics Inc has a earning quality score of B+/48.711155. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Cartesian Therapeutics Inc report earnings?

Accepted Answer

Cartesian Therapeutics Inc next earnings report is expected in 2026-02-04

Question 6

What are Cartesian Therapeutics Inc's expected earnings?

Accepted Answer

Cartesian Therapeutics Inc expected earnings is $248.37K, according to wall-street analysts.

Question 7

Did Cartesian Therapeutics Inc beat earnings expectations?

Accepted Answer

Cartesian Therapeutics Inc recent earnings of $452.0K beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.86	$-1.38	+60.46%	BEAT
Q2 '25	$-0.82	$0.5	-160.97%	MISSED
Q1 '25	$-0.71	$-0.68	-4.22%	MISSED
Q4 '24	$-0.81	$-0.59	-27.16%	MISSED
Q3 '24	$-0.92	$-1.12	+21.73%	BEAT

Cartesian Therapeutics Inc (RNAC) Price

RNAC Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ